tiprankstipranks
Clarus Therapeutics Holdings (CRXT)
OTHER OTC:CRXT
US Market

Clarus Therapeutics Holdings (CRXT) Financial Statements

0 Followers

Clarus Therapeutics Holdings Financial Overview

Clarus Therapeutics Holdings's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Clarus Therapeutics Holdings is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 4.05M$ 4.01M$ 4.56M
Gross Profit$ 2.89M$ 3.35M$ 3.27M
EBIT$ -8.67M$ -12.90M$ -2.37M
EBITDA$ -8.67M$ -12.90M$ -2.36M
Net Income Common Stockholders$ -10.69M$ -14.87M$ -3.89M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.14M$ 19.17M$ 26.41M
Total Assets$ 48.94M$ 36.52M$ 51.71M
Total Debt$ 38.48M$ 40.51M$ 42.27M
Net Debt$ 29.35M$ 21.33M$ 15.85M
Total Liabilities$ 62.00M$ 66.88M$ 67.63M
Stockholders Equity$ -13.06M$ -30.36M$ -15.92M
Cash Flow-
Free Cash Flow$ -17.50M$ -17.28M$ -9.34M
Operating Cash Flow$ -17.50M$ -17.27M$ -9.33M
Investing Cash Flow$ 0.00$ -10.00K$ -5.00K
Financing Cash Flow$ 27.54M$ 0.00$ 13.80M
Currency in USD

Clarus Therapeutics Holdings Earnings and Revenue History

Clarus Therapeutics Holdings Debt to Assets

Clarus Therapeutics Holdings Cash Flow

Clarus Therapeutics Holdings Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis